Thermo Fisher Scientific Inc. (US) and Agilent Technologies, Inc. (US) are Leading Players in the High-Throughput Screening (HTS) Market
The global high-throughput screening (HTS) market size is projected to reach USD 50.2 billion by 2029 from USD 28.8 billion in 2024, at a CAGR of 11.8% during the forecast period. Major factors driving the growth of the high throughput screening (HTS) market include rising R&D investments by pharmaceutical and biotechnology companies, ongoing technological advancements in the high throughput screening instruments and systems, and the growing adoption of an open innovation model by pharmaceutical and research institutions. Furthermore, the increasing utilization of High-throughput screening systems for drug repurposing, and novel therapeutic research further supports the market’s growth.
The prominent players in the global high-throughput screening (HTS) market are Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity, Inc. (US), Tecan Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), Mettler-Toledo International Inc. (US), Lonza (Switzerland), Waters Corporation (US), Sartorius AG (Germany), Eppendorf SE (Germany), Porvair Plc (UK), Greiner AG (Austria), Charles River Laboratories (US), Eurofins Scientific (Europe), Hamilton Company (US), Aurora Biomed Inc. (Canada), Gilson Incorporated (US), Brand GmbH+Co KG (Germany), BMG Labtech GmbH (Germany), DIANA Biotechnologies, A.S. (Czech Republic), Creative Biolabs (US), HighRes Biosolutions (US), Biomat Srl, (Italy), Axxam S.p.A. (Italy), Sygnature Discovery Limited (UK), and Crown Bioscience (US).
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific Inc. is a major player in the high-throughput screening (HTS) market, offering a wide range of high-throughput screening products and solutions for drug discovery and life science & biochemical research. Their offerings include automated liquid handling systems, high-content screening instruments, microplate readers, and various laboratory consumables that aid scientists in processing large amounts of samples and data rapidly. Additionally, the company provides custom assay development and high throughput screening services. Furthermore, the company maintains its leading position in the market by utilizing various organic and inorganic growth strategies such as product launches, agreements, joint ventures, and acquisitions. Thermo Fisher invested approximately 3% of its 2023 annual revenue towards research and development to promote continuous innovation and increase the depth of their offerings. The company invested approximately 3% of its 2023 annual revenue towards research and development.
Agilent Technologies, Inc (US)
Agilent is a key player in the high throughput screening (HTS) market and offers highly customizable and configurable high throughput screening (HTS) solutions, allowing customers to tailor their systems to specific needs and optimize screening workflows. The company also offers services such as custom microplate development. Agilent’s strong market position in the high-throughput screening market can be attributed to its focus on various growth strategies like the 2023 launch of the new Gen6 software for enhancing the capabilities of its BioTek detection instruments and the acquisition of e-MSion (US) to enhance its mass spectrometer product performance. Furthermore, Agilent's strategic focus on technology leadership enables them to introduce innovative HTS products through continuous research and development. These factors combined with the company’s strong brand recognition support the position of Agilent as a trusted and preferred partner in the HTS market.
Merck KGaA (Germany)
Merck KGaA is one of the leading pharmaceutical, life science, and chemical manufacturing companies, manufacturing and distributing biochemicals, equipment, and other essential products for research, industrial, and commercial end users. The company has a strong high throughput screening product portfolio offered at competitive prices, a wide global reach, and strong customer relationships. The company offers reagents, consumables, devices, instruments, software, and services for scientific discovery in addition to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, flow cytometry kits, and instruments These products and services are used by pharmaceutical companies, academic research institutions, and government agencies to accelerate the drug discovery process and life science & biochemical research.
Related Reports:
High-Throughput Screening (HTS) Market by Offering (Instruments, Consumables (Reagents, Kits), Software, Services), Technology (Cell-based Assays, Lab-on-Chip, Label-free), Application (Drug Discovery, Life Sciences Research) - Global Forecast to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
